Magnetocardiography (MCG) in Asymptomatic Individuals - Pilot Trial

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00572442

Enrollment

Registered

2007-12-13

Start date

2007-12-31

Completion date

2009-12-31

Last updated

2009-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Non-invasive heart scan, MCG, Cardiac Risk Factors, healthy volunteers

Brief summary

The purpose of this research study is to perform serial magnetocardiographs (MCG)and cardiovascular risk factor assessments on individuals with no symptoms or history of heart disease. This small sized study of MCG in healthy individuals will allow for data collection for power analysis for a larger prospective trial. Volunteers are not compensated or paid.

Detailed description

The Magnetocardiography (MCG) has been approved by the U.S Food and Drug Administration (FDA) as a tool to measure the heart's magnetic field.However, it is not yet approved for the specific diagnosis of coronary artery disease. The MCG scan is entirely non-invasive, rapid and no risk, since it does not require stress provocation, radiation, or use of medication or contrast. In this study, the MCG will be used to compare the scans of normal, healthy volunteers to those which have been previously or are currently being collected in subjects with known heart disease.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Subjects without chest pain and known heart diseases. * Subjects \> or = 18 years of age.

Exclusion criteria

* Heart disease patients * Patients with chest pain * Subjects with magnetic metal fragments in the head or torso * Subjects unable to consent * Minors \< 18 years of age * Subjects unable to lie flat for the examination

Countries

United States

Outcome results